Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.4K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MLLT3 YEATS domain binds histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking transcription and RNA signaling to regulate hematopoiesis.

Cell reports·2026
Same author

Characterization and first application of a new <sup>236</sup>Np spike for (A)MS measurements of <sup>237</sup>Np.

Talanta·2026
Same author

Perioperative and Oncological Outcomes of Colorectal Cancer Surgery in Obese Patients: A Multicenter Retrospective Study.

Annals of gastroenterological surgery·2026
Same author

Timing and risk factors for peristomal granulation in pediatric tracheostomy patients.

International journal of pediatric otorhinolaryngology·2026
Same author

Clinical Impact of Nivolumab in Sinonasal Mucosal Melanoma: A 14-Year Single-Center Retrospective Study and Comprehensive Literature Review.

Cancers·2026
Same author

Impact of Aspirin on Recurrence Prevention After Curative Resection for Stage I-III Colorectal Cancer: A Multi-Institutional Retrospective Study.

Journal of surgical oncology·2026

Related Experiment Video

Updated: Oct 18, 2025

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

19.8K

In vivo Leukemogenesis Model Using Retrovirus Transduction.

Hiroshi Okuda1, Akihiko Yokoyama1

  • 1Tsuruoka Metabolomics Laboratory, National Cancer Center, Yamagata, Japan.

Bio-Protocol
|October 1, 2021
PubMed
Summary

This study details a retroviral gene transduction protocol for a murine leukemia model. This model aids research into acute leukemia mechanisms driven by mixed-lineage leukemia (MLL) gene rearrangements.

Keywords:
LeukemiaLeukemogenesisMLL fusionMixed lineage leukemiaMouse model

More Related Videos

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.1K
Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia
09:43

Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia

Published on: June 9, 2023

2.3K

Related Experiment Videos

Last Updated: Oct 18, 2025

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

19.8K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.1K
Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia
09:43

Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia

Published on: June 9, 2023

2.3K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Leukemia can arise from genetic alterations like chromosomal translocations.
  • Mixed-lineage leukemia (MLL) gene rearrangements create fusion genes that drive acute leukemia.
  • Murine models are crucial for studying leukemia development.

Purpose of the Study:

  • To provide a detailed protocol for a specific murine leukemia model.
  • To facilitate research on the mechanisms of acute leukemia onset.
  • To standardize the use of retroviral gene transduction in leukemia research.

Main Methods:

  • Retroviral gene transduction in mice.
  • Generation of MLL fusion genes.
  • Establishment of a murine leukemia model.

Main Results:

  • A reproducible protocol for a retroviral gene transduction-mediated murine leukemia model is presented.
  • The model allows for the study of oncogenic MLL fusion gene products.
  • This method has been widely used in leukemia research.

Conclusions:

  • The described protocol offers a valuable tool for investigating acute leukemia pathogenesis.
  • Standardized murine models are essential for advancing leukemia research.
  • Understanding MLL-driven leukemia mechanisms is critical for therapeutic development.